Biogen stock heads for biggest weekly rally in more than 2 decades, UBS analyst targets more gainsMarket Watch • 06/11/21
BIIB Stock: 9 Things to Know About Biogen's Alzheimer Drug Approval ControversyInvestorPlace • 06/11/21
Third member of prestigious FDA panel resigns over approval of Biogen's Alzheimer's drugCNBC • 06/10/21
Biogen's Alzheimer's drug could cost Medicare billions of dollars a year, report findsCNBC • 06/10/21
New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA® (nusinersen) and Biogen's Commitment to Innovation in SMA TherapyGlobeNewsWire • 06/10/21
Biogen's hefty price tag for new drug forecast to spark Alzheimer's research resurgenceProactive Investors • 06/09/21
Biogen expects its $56,000 Alzheimer's drug to be covered by Medicare for 'most' patientsMarket Watch • 06/08/21